Login
$FRMM
$3.50 +$0.12 (3.4%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Cash
Cash and cash equivalents
Restricted cash equivalents
Accounts receivable
Loans receivable, current
Prepaid expenses and other current assets
Current assets of discontinued operations
Total Current Assets
Marketable securities
Other assets of discontinued operations
Non-marketable securities
Digital assets
Loans receivable, net of current portion
Staking receivables
Property and equipment, net
Right of use assets - operating
Total Assets
Accounts payable
Accounts payable – related parties
Accrued expenses
Accrued expenses - related parties
Related Party
Total accrued expenses - related parties
Right of use liabilities - operating
Loans payable - current portion
Convertible Preferred stock liability
Loans payable related parties - current portion
Collateralized loan - current portion
Current liabilities of discontinued operations
Total Current Liabilities
Deferred tax liability
Convertible debt, net at fair value
Derivative liabilities
Long term liabilities of discontinued operations
Collateralized loan - non current
Total Liabilities
Stockholders’ Equity:
Preferred stock, value
Class B Convertible Preferred Stock
Total preferred stock, value
Class C Preferred Stock; 1 share authorized, issued and outstanding at March 31, 2023 and December 31, 2022
Common stock, $0.0001 par value; 5,000,000,000 shares authorized; 13,210,122 and 19,012,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Preferred Stock
Total common stock, $0.0001 par value; 5,000,000,000 shares authorized; 13,210,122 and 19,012,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Treasury stock 645,043 and 0 shares at September 30, 2025 and December 31, 2024, respectively
Treasury stock 3,170 and 0 shares at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support